Trial 5U-14-1


Randomized Controlled Study Comparing AEZS-108 with Doxorubicin As Second Line Therapy For Locally Advanced, Recurrent Or Metastatic Endometrial Cancer

Type: Treatment
Phase: Phase III
Status: Not Open (Closed)
Treatments: Chemotherapy: Systemic
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Koji Matsuo, M.D.
Other Trial Staff:  Grace Facio, R.N., Marissa Aldana, D.M., Yvonne Flores, D.M., Yanli Wang, D.M., Kristy Watkins, R.N.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.